Department of Hygiene and Preventive Medicine, Fukushima Medical University School of Medicine: 1 Hikarigaoka, Fukushima, Japan.
Geriatr Gerontol Int. 2020 Nov;20(11):1085-1090. doi: 10.1111/ggi.14044. Epub 2020 Sep 22.
Polypharmacy in elderly people is a social issue and has been reported to cause not only drug adverse events, but also falls, dysfunction and cognitive decline. Those events may trigger prolonged length of hospitalization. Therefore, the aim of this study was to investigate whether polypharmacy has a prolonging effect on hospitalization.
The study subjects were 584 patients in a university hospital in Japan who had been admitted for hepatectomy, pancreaticoduodenectomy, gastrectomy or colectomy, and to whom clinical pathways had been applied. In this study, polypharmacy was defined as taking five or more regular oral medications, and prolonged hospitalization was defined as hospitalization longer than that determined by the clinical pathway. Multiple logistic regression analysis was performed to investigate whether polypharmacy affects the length of hospitalization.
The subjects were 348 males and 236 females, mean ± SD age of 65.8 ± 12.9 years. Among all subjects, 228 (39.0%) were receiving polypharmacy at admission, and the number of patients with prolonged hospitalization was 262 (44.9%). Multiple logistic regression analysis revealed that the following variables were significantly associated with prolonged hospitalization; polypharmacy (odds ratio = 1.532; 95% confidence interval = 1.010-2.327), age 50-59; 2.971 (1.216-7.7758), age 60-69; 2.405 (1.059-5.909), organ pancreas; 0.298 (0.122-0.708), operation time ≥386 min; 2.050 (1.233-3.432), intraoperative bleeding volume ≥401 mL; 2.440 (1.489-4.038), postoperative delirium; 2.395 (1.240-4.734), postoperative infection; 10.715 (4.270-33.059).
The current study revealed that polypharmacy at admission was an independent factor for prolonged hospitalization. In future, measures against polypharmacy are required, collaborating with outpatient clinics, family doctors and dispensing pharmacies. Geriatr Gerontol Int 2020; 20: 1085-1090..
老年人多种用药是一个社会问题,不仅会导致药物不良反应,还会导致跌倒、功能障碍和认知能力下降。这些事件可能会导致住院时间延长。因此,本研究旨在探讨多种用药是否会延长住院时间。
本研究的研究对象为在日本一所大学医院接受肝切除术、胰十二指肠切除术、胃切除术或结肠切除术并应用临床路径的 584 名患者。在本研究中,多种用药定义为服用五种或更多种常规口服药物,住院时间延长定义为住院时间超过临床路径确定的时间。采用多因素逻辑回归分析探讨多种用药是否影响住院时间。
受试者中男性 348 例,女性 236 例,平均年龄 65.8±12.9 岁。所有受试者中,入院时接受多种用药的有 228 例(39.0%),住院时间延长的有 262 例(44.9%)。多因素逻辑回归分析显示,以下变量与住院时间延长显著相关:多种用药(比值比=1.532;95%置信区间=1.010-2.327)、年龄 50-59 岁(比值比=2.971;95%置信区间=1.216-7.7758)、年龄 60-69 岁(比值比=2.405;95%置信区间=1.059-5.909)、器官胰腺(比值比=0.298;95%置信区间=0.122-0.708)、手术时间≥386 分钟(比值比=2.050;95%置信区间=1.233-3.432)、术中出血量≥401 毫升(比值比=2.440;95%置信区间=1.489-4.038)、术后谵妄(比值比=2.395;95%置信区间=1.240-4.734)、术后感染(比值比=10.715;95%置信区间=4.270-33.059)。
本研究表明,入院时的多种用药是住院时间延长的独立因素。未来需要采取措施控制多种用药,与门诊、家庭医生和配药机构合作。
老年医学与老年健康国际杂志 2020;20:1085-1090.